1. Armstrong CL, Goldstein B, Shera D, Ledakis GE, Tallent EM (2003) The predictive value of longitudinal neuropsychologic assessment in the early detection of brain tumor recurrence. Cancer 97(3):649–656
2. Beauchamp TL, Childress JF (2009) Principles of biomedical ethics, 6th edn. Oxford University Press, New York
3. Blonski M, Pallud J, Goze C, Mandonnet E, Rigau V, Bauchet L, Fabbro M, Beauchesne P, Baron MH, Fontaine D, Peruzzi P, Darlix A, Duffau H (2013) Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients. J Neurooncol 113(2):267–275
4. Buckner JC, Pugh SL, Shaw EG, Gilbert MR, Barker G, Coons S, Ricci P, Bullard D, Brown PD, Stelzer K, Brachman D, Suh JH, Schultz CJ, Bahary J-P, Fisher BJ, Kim H, Murha AD, Curran WJ, Metha MP (2014) Phase III study of radiation therapy with or without procarbazine, CCNU, and vincristine (PCV) in low grade glioma. RTOG 9802 with Alliance, ECOG and SWOG. Abstract 2000, 50th Annual ASCO Meeting, 2014
5. Camus A (1955) The myth of Sisyphus and other essays. Alred A. Knopf, New York